[1]
Ami, R. et al. 2026. COMPARISON OF ACTUAL COSTS AND INA-CBGS PACKAGE TARIFFS FOR EPOETIN ALFA COMBINED WITH FOLIC ACID VERSUS EPOETIN ALFA MONOTHERAPY IN CHRONIC KIDNEY DISEASE PATIENTS UNDERGOING HEMODIALYSIS. Cendekia Medika: Jurnal Stikes Al-Ma`arif Baturaja. 11, 1 (Mar. 2026), 162–168. DOI:https://doi.org/10.52235/cendekiamedika.v11i1.588.